Author response for 'Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen'

Autor:	Gunnar Mellgren, Emiel A. M. Janssen, Bjørnar Gilje, Håvard Søiland, Tone Hoel Lende, Egil S. Blix, Daniel L. Hertz, Marit Synnestvedt, Kjetil Weyde, Anna Barbro Sætersdal, Jan Terje Kvaløy, Gro Wiedswang, Ersilia Bifulco, Bjørn Naume, Thomas Helland, Ingvil Mjaaland, Elin Borgen, Steinar Hustad
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Adjuvant tamoxifen business.industry Internal medicine Premenopausal breast cancer medicine Stage (cooking) business
DOI:	10.1002/1878-0261.12865/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::21f0711788396638577e84e0563a432e https://doi.org/10.1002/1878-0261.12865/v2/response1 Zobrazit plný text záznamu